NOW ADAM Men's Multivitamin Review

Folic acid. The Supplement Facts panel reads 'Folate 680 mcg DFE (400 mcg folic acid)' — the synthetic form, not methylfolate (L-5-MTHF). Folic acid works for most people, but it needs an enzymatic conversion step that some people do inefficiently, which is why our method credits active methylfolate higher (Pietrzik 2010). An earlier version of this review said ADAM uses methylfolate; that was wrong, and the forms score has been lowered to match the label. Where ADAM's forms do beat its price is elsewhere on the panel: B12 as methylcobalamin, B6 partly as P-5-P, zinc as picolinate, and selenium, copper, manganese, chromium and molybdenum as Albion chelates. If active folate is your priority, Thorne Basic Nutrients 2/Day and SmartyPants Men's both use methylfolate.

This is the honest catch, and together with the folic acid it's why ADAM sits mid-table rather than near the top. NOW manufactures it to their in-house NPA A-rated GMP standard, which is a legitimate good-manufacturing certification — but it is NOT an independent third-party USP or NSF verification of this specific product. The practical difference: with Thorne (NSF) or Kirkland/Ritual (USP), an outside body has verified the bottle's contents match the label. With ADAM, you're trusting NOW's own quality control, which has a solid 30-year reputation but isn't the same as independent verification. For many buyers that's an acceptable trade for the price and forms; if independent certification is a hard requirement for you, choose Thorne Basic Nutrients 2/Day instead.

They're men's-health extras layered on top of the core multivitamin. Saw palmetto is a botanical commonly used for prostate support, lycopene is an antioxidant associated with prostate health, plant sterols relate to cholesterol, and CoQ10 supports cellular energy. Think of them as sensible, gap-level additions that round out a men's formula rather than therapeutic doses — they're a reason to choose ADAM over a generic unisex multi, but they won't replace a dedicated saw palmetto or CoQ10 supplement if you specifically need those at higher doses. For most men they're a nice value-add bundled into one softgel.

Only if you're vegan or vegetarian. The softgel format is actually a plus for most people — softgels are typically easy to swallow and the format suits the fat-soluble botanicals and CoQ10 in the formula. But softgels are made with gelatin (animal-derived), so this product is NOT vegan or vegetarian. If you avoid animal products, you'll want a different formula — MegaFood One Daily is vegetarian, and Thorne's capsules are more suitable. For everyone else, the softgel is a convenience, not a drawback.

Keep it realistic. NOW ADAM is a good-value men's multivitamin with chelated minerals, but no multivitamin is a longevity drug — the largest trials show only a modest cancer-incidence signal and no cardiovascular benefit over many years (Gaziano 2012; Sesso 2012). What ADAM genuinely does is fill the dietary gaps men commonly have, iron-free, in good forms, with some men's botanicals bundled in, cheaply. That's worthwhile insurance, and the chelated minerals and methyl-B12 make it better-built than most budget options, even with folic acid. It is not a health transformation, the botanicals are supportive bonuses rather than treatments, and it doesn't replace diet, exercise, and checkups.

1. [1] Pietrzik 2010 PMID 20608755 — Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics. Methylfolate is the active, circulating folate usable without enzymatic conversion, unlike folic acid. The basis for scoring ADAM's folic acid below the methylfolate products in this category.
2. [2] Gaziano 2012 (PHS II — cancer) PMID 23162860 — Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. 14,641 men, 11.2 years: a modest 8% reduction in total cancer incidence. Cited to keep the upside honest — a small long-run signal, not a men's vitality transformation.
3. [3] Sesso 2012 (PHS II — cardiovascular) PMID 23117775 — Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. Same cohort: NO cardiovascular benefit. The null behind the framing — a value men's multivitamin is gap-insurance, not a heart or longevity drug.